
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Smallpox future or investigational therapies
Introduction
Overview
Overview
Even though smallpox has been eradicated, there are undergoing studies to identify effective antiviral drugs against smallpox virus due to the potential of an outbreak as a result of bioterrorism.
Future or Investigational Therapies
Future or Investigational Therapies
Since the eradication of the smallpox virus, several antiviral drugs have been studied combating orthopox viruses in general, including:[1]
- Cidofovir
- Inhibitor of the viral DNA polymerase[2]
- Treatment of other DNA viruses
- Investigational drug for the treatment of potential adverse effects of smallpox vaccination
- Available in the IV form, with severe nephrotoxicity
- New formulations are being studied
- Poxvirus protease inhibitors
- Compounds targeting host’s intracellular pathways
- Currently being studied[6]
References
References
- β Moore, Zack S; Seward, Jane F; Lane, J Michael (2006). “Smallpox”. The Lancet. 367 (9508): 425β435. doi:10.1016/S0140-6736(06)68143-9. ISSNΒ 0140-6736.
- β Smee DF, Sidwell RW (2003). “A review of compounds exhibiting anti-orthopoxvirus activity in animal models”. Antiviral Res. 57 (1β2): 41β52. PMIDΒ 12615302.
- β Buller RM, Owens G, Schriewer J, Melman L, Beadle JR, Hostetler KY (2004). “Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model”. Virology. 318 (2): 474β81. doi:10.1016/j.virol.2003.11.015. PMIDΒ 14972516.
- β Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER (2004). “Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir”. Antimicrob Agents Chemother. 48 (2): 404β12. PMCΒ 321539. PMIDΒ 14742188.
- β Painter GR, Hostetler KY (2004). “Design and development of oral drugs for the prophylaxis and treatment of smallpox infection”. Trends Biotechnol. 22 (8): 423β7. doi:10.1016/j.tibtech.2004.06.008. PMIDΒ 15283988.
- β Yang H, Kim SK, Kim M, Reche PA, Morehead TJ, Damon IK; et al. (2005). “Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction”. J Clin Invest. 115 (2): 379β87. doi:10.1172/JCI23220. PMCΒ 546427. PMIDΒ 15690085.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: JoΓ£o AndrΓ© Alves Silva, M.D. [2]
